B

Bergenbio ASA
OSE:BGBIO

Watchlist Manager
Bergenbio ASA
OSE:BGBIO
Watchlist
Price: 1.372 NOK 1.48% Market Closed
Market Cap: 53.6m NOK

Relative Value

There is not enough data to reliably calculate the relative value of BGBIO.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

BGBIO Relative Value
Base Case
Not Available
B
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
98
vs Industry
17
Median 3Y
57 934.7
Median 5Y
950 792.2
Industry
6.9
vs History
vs Industry
Median 3Y
-95.6
Median 5Y
-1 649.6
Industry
23
Forward
-0.4
vs History
vs Industry
Median 3Y
-93.3
Median 5Y
-1 705.8
Industry
19.7
vs History
vs Industry
Median 3Y
-93.3
Median 5Y
-1 703.6
Industry
22.8
vs History
98
vs Industry
71
Median 3Y
139.9
Median 5Y
2 696.1
Industry
2.6
vs History
vs Industry
4
Median 3Y
57 353.7
Median 5Y
950 415.6
Industry
7.4
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
9.3
vs History
0
vs Industry
23
Median 3Y
-93.5
Median 5Y
-1 634.9
Industry
4.1
Forward
0.8
vs History
0
vs Industry
21
Median 3Y
-93.3
Median 5Y
-1 630.2
Industry
4.1
Forward
0.8
vs History
0
vs Industry
25
Median 3Y
-92.5
Median 5Y
-1 705
Industry
4.9
vs History
0
vs Industry
21
Median 3Y
-92.5
Median 5Y
-1 705
Industry
3.6
vs History
vs Industry
3
Median 3Y
-533.2
Median 5Y
-31 815.6
Industry
4.7

Multiples Across Competitors

BGBIO Competitors Multiples
Bergenbio ASA Competitors

Market Cap P/S P/E EV/EBITDA EV/EBIT
NO
Bergenbio ASA
OSE:BGBIO
53.6m NOK 63.2 -0.4 0.6 0.6
FR
Pharnext SCA
OTC:PNEXF
6T USD 34 627 281.5 -164 578.3 -199 850.6 -197 570
US
Abbvie Inc
NYSE:ABBV
331.1B USD 5.8 79.7 15.2 22.5
US
Amgen Inc
NASDAQ:AMGN
154.4B USD 4.5 26 14.1 23.2
US
Gilead Sciences Inc
NASDAQ:GILD
137.5B USD 4.8 23.1 10 13.8
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
114.5B USD 10.3 -115.8 24.6 25.8
US
Epizyme Inc
F:EPE
94.1B EUR 2 034.5 -519.1 -565.3 -550.2
AU
CSL Ltd
ASX:CSL
117.6B AUD 5 27.9 17.2 21.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
52.3B USD 3.7 11.6 10.2 11.5
US
Seagen Inc
F:SGT
39.3B EUR 19.6 -60.1 -64.7 -58.4
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
40B USD 17 -148.4 -664.4 -332.9
P/S Multiple
Revenue Growth P/S to Growth
NO
B
Bergenbio ASA
OSE:BGBIO
Average P/S: 3 148 131.8
63.2
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
34 627 281.5
N/A N/A
US
Abbvie Inc
NYSE:ABBV
5.8
8%
0.7
US
Amgen Inc
NASDAQ:AMGN
4.5
4%
1.1
US
Gilead Sciences Inc
NASDAQ:GILD
4.8
3%
1.6
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
10.3
10%
1
US
E
Epizyme Inc
F:EPE
2 034.5
N/A N/A
AU
CSL Ltd
ASX:CSL
5
7%
0.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
3.7
5%
0.7
US
S
Seagen Inc
F:SGT
19.6
30%
0.7
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
17
29%
0.6
P/E Multiple
Earnings Growth PEG
NO
B
Bergenbio ASA
OSE:BGBIO
Average P/E: 33.6
Negative Multiple: -0.4
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -164 578.3 N/A N/A
US
Abbvie Inc
NYSE:ABBV
79.7
88%
0.9
US
Amgen Inc
NASDAQ:AMGN
26
45%
0.6
US
Gilead Sciences Inc
NASDAQ:GILD
23.1
188%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -115.8 N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -519.1 N/A N/A
AU
CSL Ltd
ASX:CSL
27.9
16%
1.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
11.6
7%
1.7
US
S
Seagen Inc
F:SGT
Negative Multiple: -60.1 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -148.4 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
NO
B
Bergenbio ASA
OSE:BGBIO
Average EV/EBITDA: 13.1
0.6
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -199 850.6 N/A N/A
US
Abbvie Inc
NYSE:ABBV
15.2
13%
1.2
US
Amgen Inc
NASDAQ:AMGN
14.1
17%
0.8
US
Gilead Sciences Inc
NASDAQ:GILD
10
6%
1.7
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
24.6
17%
1.4
US
E
Epizyme Inc
F:EPE
Negative Multiple: -565.3 N/A N/A
AU
CSL Ltd
ASX:CSL
17.2
11%
1.6
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
10.2
11%
0.9
US
S
Seagen Inc
F:SGT
Negative Multiple: -64.7 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -664.4 N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
NO
B
Bergenbio ASA
OSE:BGBIO
Average EV/EBIT: 17
0.6
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -197 570 N/A N/A
US
Abbvie Inc
NYSE:ABBV
22.5
29%
0.8
US
Amgen Inc
NASDAQ:AMGN
23.2
32%
0.7
US
Gilead Sciences Inc
NASDAQ:GILD
13.8
11%
1.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
25.8
17%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -550.2 N/A N/A
AU
CSL Ltd
ASX:CSL
21.5
14%
1.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
11.5
11%
1
US
S
Seagen Inc
F:SGT
Negative Multiple: -58.4 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -332.9 N/A N/A